We wish to provide a correction of the colour representation of Fig. 2 in order to harmonise the colours representing the Psilocybin and the Placebo condition with the corresponding figure caption and with the colour codes from all other figures across the manuscript. Fig. 2 now depicts the Psilocybin condition in blue and the Placebo condition in yellow. The error occurred as a result of an oversight. This change does not affect the results presented in the paper and the figure legend remains unchanged.
. 2023 Jan 30;56:101841. doi: 10.1016/j.eclinm.2023.101841
Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
Robin von Rotz
a,∗, Eva M Schindowski
a, Johannes Jungwirth
a, Anna Schuldt
a, Nathalie M Rieser
a, Katharina Zahoranszky
a, Erich Seifritz
b, Albina Nowak
b, Peter Nowak
b, Lutz Jäncke
c, Katrin H Preller
a,d, Franz X Vollenweider
a,d
Robin von Rotz
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Robin von Rotz
Eva M Schindowski
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Eva M Schindowski
Johannes Jungwirth
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Johannes Jungwirth
Anna Schuldt
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Anna Schuldt
Nathalie M Rieser
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Nathalie M Rieser
Katharina Zahoranszky
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Katharina Zahoranszky
Erich Seifritz
bDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Erich Seifritz
Albina Nowak
bDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Albina Nowak
Peter Nowak
bDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Peter Nowak
Lutz Jäncke
cDivision Neuropsychology, Department of Psychology, University of Zürich, Zürich, Switzerland
Find articles by Lutz Jäncke
Katrin H Preller
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Katrin H Preller
Franz X Vollenweider
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
Find articles by Franz X Vollenweider
aNeurophenomenology of Consciousness Lab, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
bDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland
cDivision Neuropsychology, Department of Psychology, University of Zürich, Zürich, Switzerland
∗
Corresponding author. robin.vonrotz@bli.uzh.ch
d
Equal contribution.
Collection date 2023 Feb.
© 2022 The Author(s)
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PMCID: PMC9898017 PMID: 36747965
This corrects the article "Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial", 101809.

